Smith+Nephew Showcasing Chronic Wound Care Portfolio at EWMA 2026

Smith+Nephew is debuting two new wound care products this week at the European Wound Management Association (EWMA) Conference in Bremen, Germany (May 6-8).

The innovations, according to the company, are designed to support patient outcomes, simplify wound management, and ease the clinical burden of a challenge that affects up to 14.9 million people in Europe and accounts for up to 4% of healthcare spending.¹ Fully supporting clinicians and patients across the continuum of care, these purpose-built products aim to overcome the challenge of chronic wounds, drive better clinical outcomes, and help patients resume their active lifestyles.

ALLEVYN♢ COMPLETE CARE Foam Dressing has a five-layer construction with distinct modes of action capabilities focused on both wound management and pressure ulcer prevention. Enhanced ExuLOCK♢ Technology helps lock in exudate and bacteria,^2,3 releasing up to 100 times fewer bacteria than other foam dressings.^*4,5 An ExuMASK♢ Change Indicator adds confidence to wound healing by minimizing strikethrough and results in longer wear times than other foam dressings,^6,7 while advanced ShearDEFENSE♢ Unbonded Layer Technology is designed to protect from pressure injuries by dissipating shear forces.⁸

RENASYS♢ EDGE Negative Pressure Wound Therapy System is designed with simplicity at its core. Prioritizing effectiveness,⁹ intuition,¹⁰ and patient discretion,¹¹ the lightweight pump supports portability and convenience,¹² significantly improves wound outcomes,^**13 and results in an average of 88% therapy session patient compliance.¹⁴ The modular system’s low-cost  maintenance functionality removes annual servicing requirements¹⁵ while the intentional design supports patient self-care.^10,16

At EWMA (Booth E10), Smith+Nephew will showcase an integrated range of wound management solutions designed to prevent early and treat powerfully. “With chronic wound management a strategic priority, we are excited to launch ALLEVYN COMPLETE CARE Dressing and RENASYS EDGE System at EWMA,” said Rohit Kashyap, president of Advanced Wound Management at Smith+Nephew. “Our ongoing commitment to innovation and collaboration continues to drive progress in patient outcomes, as we shape the future of advanced wound care.”

Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration, and replacement of soft and hard tissue. Its 17,000 employees strive to make a difference to patients’ lives through the invention and application of new technologies across three global business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Founded in Hull, United Kingdom, in 1856, Simth+Nephew now operates in about 100 countries and generated $6.2 billion in 2025 sales. Smith+Nephew is a constituent of the FTSE100.

* Tested in-vitro (bacteria within simulated wound exudate), n=9, 3 batches. Superiority met (p <0.01) dependent on challenge volume tested.
** n=29; p<0.005

References
¹ MedTech Europe. White Paper: Shaping the Future of Wound Care in Europe. Published March 31, 2026. Accessed April 20, 2026. https://www.medtecheurope.org/wp-content/uploads/2026/03/mte-wound-care-paper-final_31.03.2026_compressed.pdf
² Smith+Nephew 2025. Internal report: CSD.AWM.25.019 V2.
³ Smith+Nephew 2025.  Internal report: CSD.AWM.25.008.
⁴ Smith+Nephew 2025. Internal report: CSD.AWM.25.021 V2.
⁵ Smith+Nephew 2025. Internal report: CSD.AWM.25.030 V2.
⁶ Atkinson L, Allen D, Costa B. Poster presented at: European Wound Management Association (EWMA); May 1–3, 2024; London, UK.
⁷ Milne C, McFee K, Costa B, Askew N, Allen D, Atkinson L. Reduced Clinical and Economic Burden Through Evidence-Based Dressing Selection for Wound Management: Findings From a Systematic Literature Review and Meta-Analysis. Int Wound J. 2026;23 Suppl 1:e70906.
⁸ Smith+Nephew 2024. Comparison of Frictional Energy Absorber Effectiveness (FEAE) in two five-layer hydrocellular polyurethane foam dressings (HPFD) containing superabsorber and masking layers. CSD.AWM.24.057 V2
⁹ Vallejo-Carmona L. Structure guided negative pressure wound therapy (NPWT): personalised tissue biomodulation with an NPWT system in adults and older adults. Journal of Wound Care Vol 34, 2025;11
¹⁰ Smith+Nephew 2022. RENASYS EDGE System Human Factors Summative Report Summary. Internal Report. CSD.AWM.22.071. 
¹¹ Smith+Nephew 2022. How the RENASYS EDGE Negative Pressure Wound Therapy System provides continuity of care to the patient Internal Report. EO.AWM.PCS270.003.V1 
¹² Smith+Nephew 2022. Summary of footprint, portability, wearability, weight and audible noise for the RENASYS EDGE system. Internal Report. CSD.AWM.22.067. 
¹³ Rossato M, Ryrie M, Robinson M, Searle R, Murdoch J. Use of NPWT as part of a Hospital @ Home wound management service. JCN Wound Care.
¹⁴ Smith+Nephew 2025. RENASYS EDGE pump retrospective activity logs analysis, relevant to patient compliance to therapy estimations. Internal Report. CSD.AWM.25.068. 
¹⁵ Smith+Nephew 2022. Summary of RENASYS EDGE pump cleaning, self-test and maintenance. Internal Report. CSD.AWM.22.068. 
¹⁶ Smith+Nephew 2023. Summary of RENASYS EDGE Pump Alarms and Alerts bench testing. Internal Report. CSD.AWM.23.017.